In the News

1855 News Items found
Sloan Kettering Institute molecular biologist Christine Mayr
In the Lab
New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease, indicating that cancer diagnostics need to go beyond the analysis of DNA mutations.
neurosurgeon and a stem cell biologist Viviane Tabar
Q&A
Learn from neurosurgeon Viviane Tabar about the standard treatment for glioblastoma, which involves surgery, chemotherapy, and radiation.
Susan Shaw, cervical cancer survivor
Feature
Hear from cervical cancer survivor Susan Shaw about how she joined the Empire Dragon Boat Team three years ago and is in the best shape of her life.
Early menopause "doesn't have to be universally terrifying or terrible," says MSK gynecologic surgeon Jennifer Mueller, above.
Feature
Learn what to expect from early menopause.
Scans of Immunotherapy performed on tumors
In the Clinic
Summary A woman with an aggressive pituitary tumor responded well to immunotherapy. This successful treatment may lead to a clinical trial testing...
Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
In the Lab
The engineered immune cells secrete powerful drugs as a layer of defense.
Five people on the beach during a sunset
Ask the Expert
Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
kratom leaves and pill
In the Lab
Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.